This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kottkamp, H. Articles by Borggrefe, M. Search for Related Content PubMed PubMed Citation Articles by Kottkamp, H. Articles by Borggrefe, M.

(Circulation. 1995;92:1159-1168.)
© 1995 American Heart Association, Inc.

Articles

Radiofrequency Catheter Ablation of Sustained Ventricular Tachycardia in Idiopathic Dilated Cardiomyopathy

Hans Kottkamp, MD; Gerhard Hindricks, MD; Xu Chen, MD; Jürgen Brunn, MD; Stephan Willems, MD; Wilhelm Haverkamp, MD; Michael Block, MD; Günter Breithardt, MD, FESC; Martin Borggrefe, MD

From the Hospital of the Westfälische Wilhelms-University, Department of Cardiology and Angiology, and Institute for Arteriosclerosis Research, Münster, Germany.

Correspondence to Hans Kottkamp, MD, Westfälische Wilhelms-Universität Münster, Medizinische Klinik und Poliklinik, Innere Medizin C (Kardiologie und Angiologie), D-48129 Münster, Germany.

Background The feasibility of radiofrequency (RF) catheter ablation for the treatment of sustained ventricular tachycardia (VT) in patients with coronary artery disease and remote myocardial infarction has recently been demonstrated. At present, therapeutic options for VT in patients with idiopathic dilated cardiomyopathy (DCM) include antiarrhythmic drugs and implantable cardioverter/defibrillators (ICD). The purpose of the present study was to investigate the feasibility of RF catheter ablation in patients with idiopathic DCM who could not be adequately treated by conventional treatment modalities because of incessant or frequent, recurrent VT.

Methods and Results RF current application for ablation of 9 VTs (mean cycle length, 402±78 ms) was attempted in 8 patients with idiopathic DCM (4 men, 4 women; mean age, 54±6 years; mean left ventricular ejection fraction, 30±9%). Inclusion criteria for ablation were incessant VT (n=4) or frequent, recurrent VT reproducibly inducible with programmed electrical stimulation (n=5). Three patients had suffered aborted sudden cardiac death, and 2 had experienced syncope. Two patients were artificially ventilated and catecholamine dependent for hemodynamic reasons at the time of attempted ablation. Potential target sites for RF current application were identified by detailed endocardial mapping during sinus rhythm, activation and entrainment mapping during VT, and pace mapping. After 7±5 RF pulses (range, 2 to 18 pulses; median, 6 pulses) applied with 32±7 W for 39±9 seconds, 6 of the 9 target VTs (67%) were rendered noninducible (4 of 4 incessant VTs and 2 of 5 chronic recurrent VTs). In 6 patients, VTs with ECG morphologies other than the target VTs were inducible after RF catheter ablation. Seven patients were on antiarrhythmic drugs during the ablation procedure and during the follow-up period of 8±5 months (range, 2 to 17 months). One patient received an ICD before RF ablation, 4 patients after RF ablation, and 1 patient after ablation of an incessant VT and before attempted ablation of frequent, recurrent VTs. One patient underwent heart transplantation 5 months after ablation in end-stage heart failure. There were no acute complications during the mapping and ablation procedure. During the follow-up period, 1 patient had been resuscitated from ventricular fibrillation 6 weeks after ablation and finally died of congestive heart failure 2 weeks later. No further episodes of incessant VT occurred in the patients who had undergone RF current application for ablation of incessant VT. A complete prevention of VT could be achieved in 2 of 8 patients, whereas in 5 patients, VT episodes were stored in the ICD devices during follow-up.

Conclusions The results of the present study indicate that RF current application for ablation of VT in a select group of patients with idiopathic DCM is feasible. The efficacy of RF ablation may be high in patients presenting with incessant VT, whereas the success rate seems to be only moderate in patients with chronic recurrent VT. In all patients, additional treatment options, including antiarrhythmic drugs, ICDs, and/or heart transplantation, were applied after RF ablation, indicating that RF ablation for this indication may be an adjunctive and not a curative treatment option.

Key Words: tachycardia • cardiomyopathy • catheter ablation

This article has been cited by other articles:

				H. Kottkamp and G. Hindricks Catheter ablation of untolerated ventricular tachycardia--a new front line Eur. Heart J., May 1, 2002; 23(9): 697 - 699. [Full Text] [PDF]

				D. Bansch, M. Castrucci, D. Bocker, G.u. Breithardt, and M. Block Ventricular tachycardias above the initially programmed tachycardia detection interval in patients with implantable cardioverter-defibrillators: Incidence, prediction and significance J. Am. Coll. Cardiol., August 1, 2000; 36(2): 557 - 565. [Abstract] [Full Text] [PDF]

				D. Bansch, D. Bocker, J.u. Brunn, M. Weber, G.u. Breithardt, and M. Block Clusters of ventricular tachycardias signify impaired survival in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillators J. Am. Coll. Cardiol., August 1, 2000; 36(2): 566 - 573. [Abstract] [Full Text] [PDF]

				H. Calkins, A. Epstein, D. Packer, A. M. Arria, J. Hummel, D. M. Gilligan, J. Trusso, M. Carlson, R. Luceri, H. Kopelman, et al. Catheter ablation of ventricular tachycardia in patients with structural heart disease using cooled radiofrequency energy: Results of a prospective multicenter study J. Am. Coll. Cardiol., June 1, 2000; 35(7): 1905 - 1914. [Abstract] [Full Text] [PDF]

				E. Sosa, M. Scanavacca, A. d'Avila, F. Oliveira, and J. A. F. Ramires Nonsurgical transthoracic epicardial catheter ablation to treat recurrent ventricular tachycardia occurring late after myocardial infarction J. Am. Coll. Cardiol., May 1, 2000; 35(6): 1442 - 1449. [Abstract] [Full Text] [PDF]

				F. G. Cosio, R. H. Anderson, K.-H. Kuck, A. Becker, M. Borggrefe, R. W. F. Campbell, F. Gaita, G. M. Guiraudon, M. Haissaguerre, J. J. Rufilanchas, et al. Living Anatomy of the Atrioventricular Junctions. A Guide to Electrophysiologic Mapping : A Consensus Statement from the Cardiac Nomenclature Study Group, Working Group of Arrhythmias, European Society of Cardiology, and the Task Force on Cardiac Nomenclature from NASPE Circulation, August 3, 1999; 100 (5): e31 - e37. [Abstract] [Full Text] [PDF]

				K. Adachi, Y. Ohnishi, T. Shima, K. Yamashiro, A. Takei, N. Tamura, and M. Yokoyama Determinant of microvolt-level T-wave alternans in patients with dilated cardiomyopathy J. Am. Coll. Cardiol., August 1, 1999; 34(2): 374 - 380. [Abstract] [Full Text] [PDF]

				F. Morady Radio-Frequency Ablation as Treatment for Cardiac Arrhythmias N. Engl. J. Med., February 18, 1999; 340(7): 534 - 544. [Full Text] [PDF]

				H. Kottkamp, G. Hindricks, E. Horst, T. Baal, C. Fechtrup, G. Breithardt, and M. Borggrefe Subendocardial and Intramural Temperature Response During Radiofrequency Catheter Ablation in Chronic Myocardial Infarction and Normal Myocardium Circulation, April 15, 1997; 95(8): 2155 - 2161. [Abstract] [Full Text]